Andrew L. Markhard

Molecular Biology · 2006–2013

A researcher in the Science corpus: 3 papers; trusts 4 researchers and is trusted by 5 researchers here, as inferred from the citation graph.

Subfields

Whom Andrew L. Markhard trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Dos D. Sarbassov

Who trusts Andrew L. Markhard overall

  1. David M. Sabatini
  2. M. Laplante
  3. L. Bar-Peled

Papers from Andrew L. Markhard's perspective

Ordered by how strongly the researchers Andrew L. Markhard trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR Complex (Science)
  2. Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. (Current Biology)
  3. mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. (Cell)
  4. mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt. (Cancer Research)
  5. Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer (Nature Medicine)
  6. mTOR·RICTOR Is the Ser473 Kinase for Akt/Protein Kinase B in 3T3-L1 Adipocytes* (Journal of Biological Chemistry)
  7. Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity (Nature)
  8. The TSC1-2 tumor suppressor controls insulin–PI3K signaling via regulation of IRS proteins (Journal of Cell Biology)
  9. PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase. (Molecules and Cells)
  10. Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor (Nature Medicine)

Their papers